Global Oncolytic Virus Manufacturing Services Market Research Report 2026(Status and Outlook)
Oncolytic virus manufacturing services refer to specialized biomanufacturing processes that involve the production of oncolytic viruses, which are viruses engineered or naturally occurring that selectively infect and kill cancer cells. These services encompass a range of activities, from virus design and development to large-scale production and quality control, ensuring that the oncolytic viruses are safe, effective, and meet regulatory standards for clinical and commercial use.
The global Oncolytic Virus Manufacturing Services market size was estimated at USD 742.5 million in 2025 and is projected to grow at a compound annual growth rate (CAGR) of 12.85% during the forecast period.
This report offers a comprehensive and in-depth analysis of the global Oncolytic Virus Manufacturing Services market, covering all critical facets from a broad macroeconomic overview to detailed micro-level insights. It examines market size, competitive landscape, emerging development trends, niche segments, key drivers and challenges, as well as conducts SWOT and value chain analyses.
The insights provided enable readers to understand the competitive dynamics within the industry and formulate effective strategies to enhance profitability and market positioning. Additionally, the report presents a clear framework for evaluating the current status and future outlook of business organizations operating in this sector.
A significant focus of this report lies in the competitive landscape of the global Oncolytic Virus Manufacturing Services market. It offers detailed profiles of major players, including their market shares, performance metrics, product portfolios, and operational status. This enables stakeholders to identify leading competitors and gain a nuanced understanding of market rivalry and structure.
In summary, this report serves as an essential resource for industry participants, investors, researchers, consultants, and business strategists, as well as anyone planning to enter or expand their presence in the Oncolytic Virus Manufacturing Services market.
Global Oncolytic Virus Manufacturing Services Market: Market Segmentation Analysis
This research report provides a detailed segmentation of the market by region (country), key manufacturers, product type, and application. Market segmentation divides the overall market into distinct subsets based on factors such as product categories, end-user industries, geographic locations, and other relevant criteria.
A clear understanding of these market segments enables decision-makers to tailor their product development, sales, and marketing strategies more effectively to meet the unique needs of each segment. Leveraging market segmentation insights can significantly enhance targeted approaches, optimize resource allocation, and accelerate product innovation cycles by aligning offerings with the specific demands of diverse customer groups.
Key Company
Recipharm (Vibalogics)
IDT Biologika
FUJIFILM Diosynth Biotechnologies
Exothera
Lonza
Creative Biolabs
Takara Bio
Libentech
ABL
Nabios
Halix
Obio Technology
Porton Advanced
WuXi ATU
Genevoyager
Market Segmentation (by Type)
Oncolytic Herpes Simplex Virus
Oncolytic Adenovirus
Oncolytic Vaccinia Virus
Others
Market Segmentation (by Application)
R&D
Biopharmaceutical Manufacturers
Others
Geographic Segmentation
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Oncolytic Virus Manufacturing Services Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 shares the main producing countries of Oncolytic Virus Manufacturing Services, their output value, profit level, regional supply, production capacity layout, etc. from the supply side.
Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 11 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment in the next five years.
Chapter 13 is the main points and conclusions of the report.
Key Reasons to Buy this Report:
Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
This enables you to anticipate market changes to remain ahead of your competitors
You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
Provision of market value data for each segment and sub-segment
Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
Includes in-depth analysis of the market from various perspectives through Porter?s five forces analysis
Provides insight into the market through Value Chain
Market dynamics scenario, along with growth opportunities of the market in the years to come
6-month post-sales analyst support
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
The global Oncolytic Virus Manufacturing Services market size was estimated at USD 742.5 million in 2025 and is projected to grow at a compound annual growth rate (CAGR) of 12.85% during the forecast period.
This report offers a comprehensive and in-depth analysis of the global Oncolytic Virus Manufacturing Services market, covering all critical facets from a broad macroeconomic overview to detailed micro-level insights. It examines market size, competitive landscape, emerging development trends, niche segments, key drivers and challenges, as well as conducts SWOT and value chain analyses.
The insights provided enable readers to understand the competitive dynamics within the industry and formulate effective strategies to enhance profitability and market positioning. Additionally, the report presents a clear framework for evaluating the current status and future outlook of business organizations operating in this sector.
A significant focus of this report lies in the competitive landscape of the global Oncolytic Virus Manufacturing Services market. It offers detailed profiles of major players, including their market shares, performance metrics, product portfolios, and operational status. This enables stakeholders to identify leading competitors and gain a nuanced understanding of market rivalry and structure.
In summary, this report serves as an essential resource for industry participants, investors, researchers, consultants, and business strategists, as well as anyone planning to enter or expand their presence in the Oncolytic Virus Manufacturing Services market.
Global Oncolytic Virus Manufacturing Services Market: Market Segmentation Analysis
This research report provides a detailed segmentation of the market by region (country), key manufacturers, product type, and application. Market segmentation divides the overall market into distinct subsets based on factors such as product categories, end-user industries, geographic locations, and other relevant criteria.
A clear understanding of these market segments enables decision-makers to tailor their product development, sales, and marketing strategies more effectively to meet the unique needs of each segment. Leveraging market segmentation insights can significantly enhance targeted approaches, optimize resource allocation, and accelerate product innovation cycles by aligning offerings with the specific demands of diverse customer groups.
Key Company
Recipharm (Vibalogics)
IDT Biologika
FUJIFILM Diosynth Biotechnologies
Exothera
Lonza
Creative Biolabs
Takara Bio
Libentech
ABL
Nabios
Halix
Obio Technology
Porton Advanced
WuXi ATU
Genevoyager
Market Segmentation (by Type)
Oncolytic Herpes Simplex Virus
Oncolytic Adenovirus
Oncolytic Vaccinia Virus
Others
Market Segmentation (by Application)
R&D
Biopharmaceutical Manufacturers
Others
Geographic Segmentation
- North America (USA, Canada, Mexico)
- Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
- Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
- South America (Brazil, Argentina, Columbia, Rest of South America)
- The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
- Industry drivers, restraints, and opportunities covered in the study
- Neutral perspective on the market performance
- Recent industry trends and developments
- Competitive landscape & strategies of key players
- Potential & niche segments and regions exhibiting promising growth covered
- Historical, current, and projected market size, in terms of value
- In-depth analysis of the Oncolytic Virus Manufacturing Services Market
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Oncolytic Virus Manufacturing Services Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 shares the main producing countries of Oncolytic Virus Manufacturing Services, their output value, profit level, regional supply, production capacity layout, etc. from the supply side.
Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 11 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment in the next five years.
Chapter 13 is the main points and conclusions of the report.
Key Reasons to Buy this Report:
Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
This enables you to anticipate market changes to remain ahead of your competitors
You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
Provision of market value data for each segment and sub-segment
Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
Includes in-depth analysis of the market from various perspectives through Porter?s five forces analysis
Provides insight into the market through Value Chain
Market dynamics scenario, along with growth opportunities of the market in the years to come
6-month post-sales analyst support
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
1 RESEARCH METHODOLOGY AND STATISTICAL SCOPE
1.1 Market Definition and Statistical Scope of Oncolytic Virus Manufacturing Services
1.2 Key Market Segments
1.2.1 Oncolytic Virus Manufacturing Services Segment by Type
1.2.2 Oncolytic Virus Manufacturing Services Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 ONCOLYTIC VIRUS MANUFACTURING SERVICES MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Oncolytic Virus Manufacturing Services Market Size (M USD) Estimates and Forecasts (2020-2035)
2.1.2 Global Oncolytic Virus Manufacturing Services Sales Estimates and Forecasts (2020-2035)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 ONCOLYTIC VIRUS MANUFACTURING SERVICES MARKET COMPETITIVE LANDSCAPE
3.1 Company Assessment Quadrant
3.2 Global Oncolytic Virus Manufacturing Services Product Life Cycle
3.3 Global Oncolytic Virus Manufacturing Services Sales by Manufacturers (2020-2025)
3.4 Global Oncolytic Virus Manufacturing Services Revenue Market Share by Manufacturers (2020-2025)
3.5 Oncolytic Virus Manufacturing Services Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Oncolytic Virus Manufacturing Services Average Price by Manufacturers (2020-2025)
3.7 Manufacturers? Manufacturing Sites, Areas Served, and Product Types
3.8 Oncolytic Virus Manufacturing Services Market Competitive Situation and Trends
3.8.1 Oncolytic Virus Manufacturing Services Market Concentration Rate
3.8.2 Global 5 and 10 Largest Oncolytic Virus Manufacturing Services Players Market Share by Revenue
3.8.3 Mergers & Acquisitions, Expansion
4 ONCOLYTIC VIRUS MANUFACTURING SERVICES INDUSTRY CHAIN ANALYSIS
4.1 Oncolytic Virus Manufacturing Services Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF ONCOLYTIC VIRUS MANUFACTURING SERVICES MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Industry News
5.4.1 New Product Developments
5.4.2 Mergers & Acquisitions
5.4.3 Expansions
5.4.4 Collaboration/Supply Contracts
5.5 PEST Analysis
5.5.1 Industry Policies Analysis
5.5.2 Economic Environment Analysis
5.5.3 Social Environment Analysis
5.5.4 Technological Environment Analysis
5.6 Global Oncolytic Virus Manufacturing Services Market Porter's Five Forces Analysis
5.6.1 Global Trade Frictions
5.6.2 U.S. Tariff Policy ? April 2025
5.6.3 Global Trade Frictions and Their Impacts to Oncolytic Virus Manufacturing Services Market
5.7 ESG Ratings of Leading Companies
6 ONCOLYTIC VIRUS MANUFACTURING SERVICES MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Oncolytic Virus Manufacturing Services Sales Market Share by Type (2020-2025)
6.3 Global Oncolytic Virus Manufacturing Services Market Size by Type (2020-2025)
6.4 Global Oncolytic Virus Manufacturing Services Price by Type (2020-2025)
7 ONCOLYTIC VIRUS MANUFACTURING SERVICES MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Oncolytic Virus Manufacturing Services Market Sales by Application (2020-2025)
7.3 Global Oncolytic Virus Manufacturing Services Market Size (M USD) by Application (2020-2025)
7.4 Global Oncolytic Virus Manufacturing Services Sales Growth Rate by Application (2020-2025)
8 ONCOLYTIC VIRUS MANUFACTURING SERVICES MARKET SALES BY REGION
8.1 Global Oncolytic Virus Manufacturing Services Sales by Region
8.1.1 Global Oncolytic Virus Manufacturing Services Sales by Region
8.1.2 Global Oncolytic Virus Manufacturing Services Sales Market Share by Region
8.2 Global Oncolytic Virus Manufacturing Services Market Size by Region
8.2.1 Global Oncolytic Virus Manufacturing Services Market Size by Region
8.2.2 Global Oncolytic Virus Manufacturing Services Market Size by Region
8.3 North America
8.3.1 North America Oncolytic Virus Manufacturing Services Sales by Country
8.3.2 North America Oncolytic Virus Manufacturing Services Market Size by Country
8.3.3 U.S. Market Overview
8.3.4 Canada Market Overview
8.3.5 Mexico Market Overview
8.4 Europe
8.4.1 Europe Oncolytic Virus Manufacturing Services Sales by Country
8.4.2 Europe Oncolytic Virus Manufacturing Services Market Size by Country
8.4.3 Germany Market Overview
8.4.4 France Market Overview
8.4.5 U.K. Market Overview
8.4.6 Italy Market Overview
8.4.7 Spain Market Overview
8.5 Asia Pacific
8.5.1 Asia Pacific Oncolytic Virus Manufacturing Services Sales by Region
8.5.2 Asia Pacific Oncolytic Virus Manufacturing Services Market Size by Region
8.5.3 China Market Overview
8.5.4 Japan Market Overview
8.5.5 South Korea Market Overview
8.5.6 India Market Overview
8.5.7 Southeast Asia Market Overview
8.6 South America
8.6.1 South America Oncolytic Virus Manufacturing Services Sales by Country
8.6.2 South America Oncolytic Virus Manufacturing Services Market Size by Country
8.6.3 Brazil Market Overview
8.6.4 Argentina Market Overview
8.6.5 Columbia Market Overview
8.7 Middle East and Africa
8.7.1 Middle East and Africa Oncolytic Virus Manufacturing Services Sales by Region
8.7.2 Middle East and Africa Oncolytic Virus Manufacturing Services Market Size by Region
8.7.3 Saudi Arabia Market Overview
8.7.4 UAE Market Overview
8.7.5 Egypt Market Overview
8.7.6 Nigeria Market Overview
8.7.7 South Africa Market Overview
9 ONCOLYTIC VIRUS MANUFACTURING SERVICES MARKET PRODUCTION BY REGION
9.1 Global Production of Oncolytic Virus Manufacturing Services by Region(2020-2025)
9.2 Global Oncolytic Virus Manufacturing Services Revenue Market Share by Region (2020-2025)
9.3 Global Oncolytic Virus Manufacturing Services Production, Revenue, Price and Gross Margin (2020-2025)
9.4 North America Oncolytic Virus Manufacturing Services Production
9.4.1 North America Oncolytic Virus Manufacturing Services Production Growth Rate (2020-2025)
9.4.2 North America Oncolytic Virus Manufacturing Services Production, Revenue, Price and Gross Margin (2020-2025)
9.5 Europe Oncolytic Virus Manufacturing Services Production
9.5.1 Europe Oncolytic Virus Manufacturing Services Production Growth Rate (2020-2025)
9.5.2 Europe Oncolytic Virus Manufacturing Services Production, Revenue, Price and Gross Margin (2020-2025)
9.6 Japan Oncolytic Virus Manufacturing Services Production (2020-2025)
9.6.1 Japan Oncolytic Virus Manufacturing Services Production Growth Rate (2020-2025)
9.6.2 Japan Oncolytic Virus Manufacturing Services Production, Revenue, Price and Gross Margin (2020-2025)
9.7 China Oncolytic Virus Manufacturing Services Production (2020-2025)
9.7.1 China Oncolytic Virus Manufacturing Services Production Growth Rate (2020-2025)
9.7.2 China Oncolytic Virus Manufacturing Services Production, Revenue, Price and Gross Margin (2020-2025)
10 KEY COMPANIES PROFILE
10.1 Recipharm (Vibalogics)
10.1.1 Recipharm (Vibalogics) Basic Information
10.1.2 Recipharm (Vibalogics) Oncolytic Virus Manufacturing Services Product Overview
10.1.3 Recipharm (Vibalogics) Oncolytic Virus Manufacturing Services Product Market Performance
10.1.4 Recipharm (Vibalogics) Business Overview
10.1.5 Recipharm (Vibalogics) SWOT Analysis
10.1.6 Recipharm (Vibalogics) Recent Developments
10.2 IDT Biologika
10.2.1 IDT Biologika Basic Information
10.2.2 IDT Biologika Oncolytic Virus Manufacturing Services Product Overview
10.2.3 IDT Biologika Oncolytic Virus Manufacturing Services Product Market Performance
10.2.4 IDT Biologika Business Overview
10.2.5 IDT Biologika SWOT Analysis
10.2.6 IDT Biologika Recent Developments
10.3 FUJIFILM Diosynth Biotechnologies
10.3.1 FUJIFILM Diosynth Biotechnologies Basic Information
10.3.2 FUJIFILM Diosynth Biotechnologies Oncolytic Virus Manufacturing Services Product Overview
10.3.3 FUJIFILM Diosynth Biotechnologies Oncolytic Virus Manufacturing Services Product Market Performance
10.3.4 FUJIFILM Diosynth Biotechnologies Business Overview
10.3.5 FUJIFILM Diosynth Biotechnologies SWOT Analysis
10.3.6 FUJIFILM Diosynth Biotechnologies Recent Developments
10.4 Exothera
10.4.1 Exothera Basic Information
10.4.2 Exothera Oncolytic Virus Manufacturing Services Product Overview
10.4.3 Exothera Oncolytic Virus Manufacturing Services Product Market Performance
10.4.4 Exothera Business Overview
10.4.5 Exothera Recent Developments
10.5 Lonza
10.5.1 Lonza Basic Information
10.5.2 Lonza Oncolytic Virus Manufacturing Services Product Overview
10.5.3 Lonza Oncolytic Virus Manufacturing Services Product Market Performance
10.5.4 Lonza Business Overview
10.5.5 Lonza Recent Developments
10.6 Creative Biolabs
10.6.1 Creative Biolabs Basic Information
10.6.2 Creative Biolabs Oncolytic Virus Manufacturing Services Product Overview
10.6.3 Creative Biolabs Oncolytic Virus Manufacturing Services Product Market Performance
10.6.4 Creative Biolabs Business Overview
10.6.5 Creative Biolabs Recent Developments
10.7 Takara Bio
10.7.1 Takara Bio Basic Information
10.7.2 Takara Bio Oncolytic Virus Manufacturing Services Product Overview
10.7.3 Takara Bio Oncolytic Virus Manufacturing Services Product Market Performance
10.7.4 Takara Bio Business Overview
10.7.5 Takara Bio Recent Developments
10.8 Libentech
10.8.1 Libentech Basic Information
10.8.2 Libentech Oncolytic Virus Manufacturing Services Product Overview
10.8.3 Libentech Oncolytic Virus Manufacturing Services Product Market Performance
10.8.4 Libentech Business Overview
10.8.5 Libentech Recent Developments
10.9 ABL
10.9.1 ABL Basic Information
10.9.2 ABL Oncolytic Virus Manufacturing Services Product Overview
10.9.3 ABL Oncolytic Virus Manufacturing Services Product Market Performance
10.9.4 ABL Business Overview
10.9.5 ABL Recent Developments
10.10 Nabios
10.10.1 Nabios Basic Information
10.10.2 Nabios Oncolytic Virus Manufacturing Services Product Overview
10.10.3 Nabios Oncolytic Virus Manufacturing Services Product Market Performance
10.10.4 Nabios Business Overview
10.10.5 Nabios Recent Developments
10.11 Halix
10.11.1 Halix Basic Information
10.11.2 Halix Oncolytic Virus Manufacturing Services Product Overview
10.11.3 Halix Oncolytic Virus Manufacturing Services Product Market Performance
10.11.4 Halix Business Overview
10.11.5 Halix Recent Developments
10.12 Obio Technology
10.12.1 Obio Technology Basic Information
10.12.2 Obio Technology Oncolytic Virus Manufacturing Services Product Overview
10.12.3 Obio Technology Oncolytic Virus Manufacturing Services Product Market Performance
10.12.4 Obio Technology Business Overview
10.12.5 Obio Technology Recent Developments
10.13 Porton Advanced
10.13.1 Porton Advanced Basic Information
10.13.2 Porton Advanced Oncolytic Virus Manufacturing Services Product Overview
10.13.3 Porton Advanced Oncolytic Virus Manufacturing Services Product Market Performance
10.13.4 Porton Advanced Business Overview
10.13.5 Porton Advanced Recent Developments
10.14 WuXi ATU
10.14.1 WuXi ATU Basic Information
10.14.2 WuXi ATU Oncolytic Virus Manufacturing Services Product Overview
10.14.3 WuXi ATU Oncolytic Virus Manufacturing Services Product Market Performance
10.14.4 WuXi ATU Business Overview
10.14.5 WuXi ATU Recent Developments
10.15 Genevoyager
10.15.1 Genevoyager Basic Information
10.15.2 Genevoyager Oncolytic Virus Manufacturing Services Product Overview
10.15.3 Genevoyager Oncolytic Virus Manufacturing Services Product Market Performance
10.15.4 Genevoyager Business Overview
10.15.5 Genevoyager Recent Developments
11 ONCOLYTIC VIRUS MANUFACTURING SERVICES MARKET FORECAST BY REGION
11.1 Global Oncolytic Virus Manufacturing Services Market Size Forecast
11.2 Global Oncolytic Virus Manufacturing Services Market Forecast by Region
11.2.1 North America Market Size Forecast by Country
11.2.2 Europe Oncolytic Virus Manufacturing Services Market Size Forecast by Country
11.2.3 Asia Pacific Oncolytic Virus Manufacturing Services Market Size Forecast by Region
11.2.4 South America Oncolytic Virus Manufacturing Services Market Size Forecast by Country
11.2.5 Middle East and Africa Forecasted Sales of Oncolytic Virus Manufacturing Services by Country
12 FORECAST MARKET BY TYPE AND BY APPLICATION (2026-2035)
12.1 Global Oncolytic Virus Manufacturing Services Market Forecast by Type (2026-2035)
12.1.1 Global Forecasted Sales of Oncolytic Virus Manufacturing Services by Type (2026-2035)
12.1.2 Global Oncolytic Virus Manufacturing Services Market Size Forecast by Type (2026-2035)
12.1.3 Global Forecasted Price of Oncolytic Virus Manufacturing Services by Type (2026-2035)
12.2 Global Oncolytic Virus Manufacturing Services Market Forecast by Application (2026-2035)
12.2.1 Global Oncolytic Virus Manufacturing Services Sales (K Units) Forecast by Application
12.2.2 Global Oncolytic Virus Manufacturing Services Market Size (M USD) Forecast by Application (2026-2035)
13 CONCLUSION AND KEY FINDINGS
1.1 Market Definition and Statistical Scope of Oncolytic Virus Manufacturing Services
1.2 Key Market Segments
1.2.1 Oncolytic Virus Manufacturing Services Segment by Type
1.2.2 Oncolytic Virus Manufacturing Services Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 ONCOLYTIC VIRUS MANUFACTURING SERVICES MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Oncolytic Virus Manufacturing Services Market Size (M USD) Estimates and Forecasts (2020-2035)
2.1.2 Global Oncolytic Virus Manufacturing Services Sales Estimates and Forecasts (2020-2035)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 ONCOLYTIC VIRUS MANUFACTURING SERVICES MARKET COMPETITIVE LANDSCAPE
3.1 Company Assessment Quadrant
3.2 Global Oncolytic Virus Manufacturing Services Product Life Cycle
3.3 Global Oncolytic Virus Manufacturing Services Sales by Manufacturers (2020-2025)
3.4 Global Oncolytic Virus Manufacturing Services Revenue Market Share by Manufacturers (2020-2025)
3.5 Oncolytic Virus Manufacturing Services Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Oncolytic Virus Manufacturing Services Average Price by Manufacturers (2020-2025)
3.7 Manufacturers? Manufacturing Sites, Areas Served, and Product Types
3.8 Oncolytic Virus Manufacturing Services Market Competitive Situation and Trends
3.8.1 Oncolytic Virus Manufacturing Services Market Concentration Rate
3.8.2 Global 5 and 10 Largest Oncolytic Virus Manufacturing Services Players Market Share by Revenue
3.8.3 Mergers & Acquisitions, Expansion
4 ONCOLYTIC VIRUS MANUFACTURING SERVICES INDUSTRY CHAIN ANALYSIS
4.1 Oncolytic Virus Manufacturing Services Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF ONCOLYTIC VIRUS MANUFACTURING SERVICES MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Industry News
5.4.1 New Product Developments
5.4.2 Mergers & Acquisitions
5.4.3 Expansions
5.4.4 Collaboration/Supply Contracts
5.5 PEST Analysis
5.5.1 Industry Policies Analysis
5.5.2 Economic Environment Analysis
5.5.3 Social Environment Analysis
5.5.4 Technological Environment Analysis
5.6 Global Oncolytic Virus Manufacturing Services Market Porter's Five Forces Analysis
5.6.1 Global Trade Frictions
5.6.2 U.S. Tariff Policy ? April 2025
5.6.3 Global Trade Frictions and Their Impacts to Oncolytic Virus Manufacturing Services Market
5.7 ESG Ratings of Leading Companies
6 ONCOLYTIC VIRUS MANUFACTURING SERVICES MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Oncolytic Virus Manufacturing Services Sales Market Share by Type (2020-2025)
6.3 Global Oncolytic Virus Manufacturing Services Market Size by Type (2020-2025)
6.4 Global Oncolytic Virus Manufacturing Services Price by Type (2020-2025)
7 ONCOLYTIC VIRUS MANUFACTURING SERVICES MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Oncolytic Virus Manufacturing Services Market Sales by Application (2020-2025)
7.3 Global Oncolytic Virus Manufacturing Services Market Size (M USD) by Application (2020-2025)
7.4 Global Oncolytic Virus Manufacturing Services Sales Growth Rate by Application (2020-2025)
8 ONCOLYTIC VIRUS MANUFACTURING SERVICES MARKET SALES BY REGION
8.1 Global Oncolytic Virus Manufacturing Services Sales by Region
8.1.1 Global Oncolytic Virus Manufacturing Services Sales by Region
8.1.2 Global Oncolytic Virus Manufacturing Services Sales Market Share by Region
8.2 Global Oncolytic Virus Manufacturing Services Market Size by Region
8.2.1 Global Oncolytic Virus Manufacturing Services Market Size by Region
8.2.2 Global Oncolytic Virus Manufacturing Services Market Size by Region
8.3 North America
8.3.1 North America Oncolytic Virus Manufacturing Services Sales by Country
8.3.2 North America Oncolytic Virus Manufacturing Services Market Size by Country
8.3.3 U.S. Market Overview
8.3.4 Canada Market Overview
8.3.5 Mexico Market Overview
8.4 Europe
8.4.1 Europe Oncolytic Virus Manufacturing Services Sales by Country
8.4.2 Europe Oncolytic Virus Manufacturing Services Market Size by Country
8.4.3 Germany Market Overview
8.4.4 France Market Overview
8.4.5 U.K. Market Overview
8.4.6 Italy Market Overview
8.4.7 Spain Market Overview
8.5 Asia Pacific
8.5.1 Asia Pacific Oncolytic Virus Manufacturing Services Sales by Region
8.5.2 Asia Pacific Oncolytic Virus Manufacturing Services Market Size by Region
8.5.3 China Market Overview
8.5.4 Japan Market Overview
8.5.5 South Korea Market Overview
8.5.6 India Market Overview
8.5.7 Southeast Asia Market Overview
8.6 South America
8.6.1 South America Oncolytic Virus Manufacturing Services Sales by Country
8.6.2 South America Oncolytic Virus Manufacturing Services Market Size by Country
8.6.3 Brazil Market Overview
8.6.4 Argentina Market Overview
8.6.5 Columbia Market Overview
8.7 Middle East and Africa
8.7.1 Middle East and Africa Oncolytic Virus Manufacturing Services Sales by Region
8.7.2 Middle East and Africa Oncolytic Virus Manufacturing Services Market Size by Region
8.7.3 Saudi Arabia Market Overview
8.7.4 UAE Market Overview
8.7.5 Egypt Market Overview
8.7.6 Nigeria Market Overview
8.7.7 South Africa Market Overview
9 ONCOLYTIC VIRUS MANUFACTURING SERVICES MARKET PRODUCTION BY REGION
9.1 Global Production of Oncolytic Virus Manufacturing Services by Region(2020-2025)
9.2 Global Oncolytic Virus Manufacturing Services Revenue Market Share by Region (2020-2025)
9.3 Global Oncolytic Virus Manufacturing Services Production, Revenue, Price and Gross Margin (2020-2025)
9.4 North America Oncolytic Virus Manufacturing Services Production
9.4.1 North America Oncolytic Virus Manufacturing Services Production Growth Rate (2020-2025)
9.4.2 North America Oncolytic Virus Manufacturing Services Production, Revenue, Price and Gross Margin (2020-2025)
9.5 Europe Oncolytic Virus Manufacturing Services Production
9.5.1 Europe Oncolytic Virus Manufacturing Services Production Growth Rate (2020-2025)
9.5.2 Europe Oncolytic Virus Manufacturing Services Production, Revenue, Price and Gross Margin (2020-2025)
9.6 Japan Oncolytic Virus Manufacturing Services Production (2020-2025)
9.6.1 Japan Oncolytic Virus Manufacturing Services Production Growth Rate (2020-2025)
9.6.2 Japan Oncolytic Virus Manufacturing Services Production, Revenue, Price and Gross Margin (2020-2025)
9.7 China Oncolytic Virus Manufacturing Services Production (2020-2025)
9.7.1 China Oncolytic Virus Manufacturing Services Production Growth Rate (2020-2025)
9.7.2 China Oncolytic Virus Manufacturing Services Production, Revenue, Price and Gross Margin (2020-2025)
10 KEY COMPANIES PROFILE
10.1 Recipharm (Vibalogics)
10.1.1 Recipharm (Vibalogics) Basic Information
10.1.2 Recipharm (Vibalogics) Oncolytic Virus Manufacturing Services Product Overview
10.1.3 Recipharm (Vibalogics) Oncolytic Virus Manufacturing Services Product Market Performance
10.1.4 Recipharm (Vibalogics) Business Overview
10.1.5 Recipharm (Vibalogics) SWOT Analysis
10.1.6 Recipharm (Vibalogics) Recent Developments
10.2 IDT Biologika
10.2.1 IDT Biologika Basic Information
10.2.2 IDT Biologika Oncolytic Virus Manufacturing Services Product Overview
10.2.3 IDT Biologika Oncolytic Virus Manufacturing Services Product Market Performance
10.2.4 IDT Biologika Business Overview
10.2.5 IDT Biologika SWOT Analysis
10.2.6 IDT Biologika Recent Developments
10.3 FUJIFILM Diosynth Biotechnologies
10.3.1 FUJIFILM Diosynth Biotechnologies Basic Information
10.3.2 FUJIFILM Diosynth Biotechnologies Oncolytic Virus Manufacturing Services Product Overview
10.3.3 FUJIFILM Diosynth Biotechnologies Oncolytic Virus Manufacturing Services Product Market Performance
10.3.4 FUJIFILM Diosynth Biotechnologies Business Overview
10.3.5 FUJIFILM Diosynth Biotechnologies SWOT Analysis
10.3.6 FUJIFILM Diosynth Biotechnologies Recent Developments
10.4 Exothera
10.4.1 Exothera Basic Information
10.4.2 Exothera Oncolytic Virus Manufacturing Services Product Overview
10.4.3 Exothera Oncolytic Virus Manufacturing Services Product Market Performance
10.4.4 Exothera Business Overview
10.4.5 Exothera Recent Developments
10.5 Lonza
10.5.1 Lonza Basic Information
10.5.2 Lonza Oncolytic Virus Manufacturing Services Product Overview
10.5.3 Lonza Oncolytic Virus Manufacturing Services Product Market Performance
10.5.4 Lonza Business Overview
10.5.5 Lonza Recent Developments
10.6 Creative Biolabs
10.6.1 Creative Biolabs Basic Information
10.6.2 Creative Biolabs Oncolytic Virus Manufacturing Services Product Overview
10.6.3 Creative Biolabs Oncolytic Virus Manufacturing Services Product Market Performance
10.6.4 Creative Biolabs Business Overview
10.6.5 Creative Biolabs Recent Developments
10.7 Takara Bio
10.7.1 Takara Bio Basic Information
10.7.2 Takara Bio Oncolytic Virus Manufacturing Services Product Overview
10.7.3 Takara Bio Oncolytic Virus Manufacturing Services Product Market Performance
10.7.4 Takara Bio Business Overview
10.7.5 Takara Bio Recent Developments
10.8 Libentech
10.8.1 Libentech Basic Information
10.8.2 Libentech Oncolytic Virus Manufacturing Services Product Overview
10.8.3 Libentech Oncolytic Virus Manufacturing Services Product Market Performance
10.8.4 Libentech Business Overview
10.8.5 Libentech Recent Developments
10.9 ABL
10.9.1 ABL Basic Information
10.9.2 ABL Oncolytic Virus Manufacturing Services Product Overview
10.9.3 ABL Oncolytic Virus Manufacturing Services Product Market Performance
10.9.4 ABL Business Overview
10.9.5 ABL Recent Developments
10.10 Nabios
10.10.1 Nabios Basic Information
10.10.2 Nabios Oncolytic Virus Manufacturing Services Product Overview
10.10.3 Nabios Oncolytic Virus Manufacturing Services Product Market Performance
10.10.4 Nabios Business Overview
10.10.5 Nabios Recent Developments
10.11 Halix
10.11.1 Halix Basic Information
10.11.2 Halix Oncolytic Virus Manufacturing Services Product Overview
10.11.3 Halix Oncolytic Virus Manufacturing Services Product Market Performance
10.11.4 Halix Business Overview
10.11.5 Halix Recent Developments
10.12 Obio Technology
10.12.1 Obio Technology Basic Information
10.12.2 Obio Technology Oncolytic Virus Manufacturing Services Product Overview
10.12.3 Obio Technology Oncolytic Virus Manufacturing Services Product Market Performance
10.12.4 Obio Technology Business Overview
10.12.5 Obio Technology Recent Developments
10.13 Porton Advanced
10.13.1 Porton Advanced Basic Information
10.13.2 Porton Advanced Oncolytic Virus Manufacturing Services Product Overview
10.13.3 Porton Advanced Oncolytic Virus Manufacturing Services Product Market Performance
10.13.4 Porton Advanced Business Overview
10.13.5 Porton Advanced Recent Developments
10.14 WuXi ATU
10.14.1 WuXi ATU Basic Information
10.14.2 WuXi ATU Oncolytic Virus Manufacturing Services Product Overview
10.14.3 WuXi ATU Oncolytic Virus Manufacturing Services Product Market Performance
10.14.4 WuXi ATU Business Overview
10.14.5 WuXi ATU Recent Developments
10.15 Genevoyager
10.15.1 Genevoyager Basic Information
10.15.2 Genevoyager Oncolytic Virus Manufacturing Services Product Overview
10.15.3 Genevoyager Oncolytic Virus Manufacturing Services Product Market Performance
10.15.4 Genevoyager Business Overview
10.15.5 Genevoyager Recent Developments
11 ONCOLYTIC VIRUS MANUFACTURING SERVICES MARKET FORECAST BY REGION
11.1 Global Oncolytic Virus Manufacturing Services Market Size Forecast
11.2 Global Oncolytic Virus Manufacturing Services Market Forecast by Region
11.2.1 North America Market Size Forecast by Country
11.2.2 Europe Oncolytic Virus Manufacturing Services Market Size Forecast by Country
11.2.3 Asia Pacific Oncolytic Virus Manufacturing Services Market Size Forecast by Region
11.2.4 South America Oncolytic Virus Manufacturing Services Market Size Forecast by Country
11.2.5 Middle East and Africa Forecasted Sales of Oncolytic Virus Manufacturing Services by Country
12 FORECAST MARKET BY TYPE AND BY APPLICATION (2026-2035)
12.1 Global Oncolytic Virus Manufacturing Services Market Forecast by Type (2026-2035)
12.1.1 Global Forecasted Sales of Oncolytic Virus Manufacturing Services by Type (2026-2035)
12.1.2 Global Oncolytic Virus Manufacturing Services Market Size Forecast by Type (2026-2035)
12.1.3 Global Forecasted Price of Oncolytic Virus Manufacturing Services by Type (2026-2035)
12.2 Global Oncolytic Virus Manufacturing Services Market Forecast by Application (2026-2035)
12.2.1 Global Oncolytic Virus Manufacturing Services Sales (K Units) Forecast by Application
12.2.2 Global Oncolytic Virus Manufacturing Services Market Size (M USD) Forecast by Application (2026-2035)
13 CONCLUSION AND KEY FINDINGS
LIST OF TABLES
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Global Oncolytic Virus Manufacturing Services Market Size by Type (M USD)
Table 4. Global Oncolytic Virus Manufacturing Services Market Size by Application
Table 5. Oncolytic Virus Manufacturing Services Market Size Comparison by Region (M USD)
Table 6. Global Oncolytic Virus Manufacturing Services Sales (K Units) by Manufacturers (2020-2025)
Table 7. Global Oncolytic Virus Manufacturing Services Sales Market Share by Manufacturers (2020-2025)
Table 8. Global Oncolytic Virus Manufacturing Services Revenue (M USD) by Manufacturers (2020-2025)
Table 9. Global Oncolytic Virus Manufacturing Services Revenue Share by Manufacturers (2020-2025)
Table 10. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Oncolytic Virus Manufacturing Services as of 2025)
Table 11. Global Market Oncolytic Virus Manufacturing Services Average Price (USD/Unit) of Key Manufacturers (2020-2025)
Table 12. Manufacturers? Manufacturing Sites, Areas Served
Table 13. Manufacturers? Product Type
Table 14. Global Oncolytic Virus Manufacturing Services Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 15. Mergers & Acquisitions, Expansion Plans
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Oncolytic Virus Manufacturing Services Market Challenges
Table 22. Goldman Sachs' forecast real GDP growth rate for 2025-2026
Table 23. S&P Global ' Forecast Real GDP Growth Rate For 2025-2027
Table 24. World Bank ' Forecast Real GDP Growth Rate For 2025-2026
Table 25. The Tariff Rates Imposed by the United States on Major Commodity Trading Countries
Table 26. Global Oncolytic Virus Manufacturing Services Sales by Type (K Units)
Table 27. Global Oncolytic Virus Manufacturing Services Market Size by Type (M USD)
Table 28. Global Oncolytic Virus Manufacturing Services Sales (K Units) by Type (2020-2025)
Table 29. Global Oncolytic Virus Manufacturing Services Sales Market Share by Type (2020-2025)
Table 30. Global Oncolytic Virus Manufacturing Services Market Size (M USD) by Type (2020-2025)
Table 31. Global Oncolytic Virus Manufacturing Services Market Share by Type (2020-2025)
Table 32. Global Oncolytic Virus Manufacturing Services Price (USD/Unit) by Type (2020-2025)
Table 33. Global Oncolytic Virus Manufacturing Services Sales (K Units) by Application
Table 34. Global Oncolytic Virus Manufacturing Services Market Size by Application
Table 35. Global Oncolytic Virus Manufacturing Services Sales by Application (2020-2025) & (K Units)
Table 36. Global Oncolytic Virus Manufacturing Services Sales Market Share by Application (2020-2025)
Table 37. Global Oncolytic Virus Manufacturing Services Market Size by Application (2020-2025) & (M USD)
Table 38. Global Oncolytic Virus Manufacturing Services Market Share by Application (2020-2025)
Table 39. Global Oncolytic Virus Manufacturing Services Sales Growth Rate by Application (2020-2025)
Table 40. Global Oncolytic Virus Manufacturing Services Sales by Region (2020-2025) & (K Units)
Table 41. Global Oncolytic Virus Manufacturing Services Sales Market Share by Region (2020-2025)
Table 42. Global Oncolytic Virus Manufacturing Services Market Size by Region (2020-2025) & (M USD)
Table 43. Global Oncolytic Virus Manufacturing Services Market Size by Region (2020-2025)
Table 44. North America Oncolytic Virus Manufacturing Services Sales by Country (2020-2025) & (K Units)
Table 45. North America Oncolytic Virus Manufacturing Services Market Size by Country (2020-2025) & (M USD)
Table 46. Europe Oncolytic Virus Manufacturing Services Sales by Country (2020-2025) & (K Units)
Table 47. Europe Oncolytic Virus Manufacturing Services Market Size by Country (2020-2025) & (M USD)
Table 48. Asia Pacific Oncolytic Virus Manufacturing Services Sales by Region (2020-2025) & (K Units)
Table 49. Asia Pacific Oncolytic Virus Manufacturing Services Market Size by Region (2020-2025) & (M USD)
Table 50. South America Oncolytic Virus Manufacturing Services Sales by Country (2020-2025) & (K Units)
Table 51. South America Oncolytic Virus Manufacturing Services Market Size by Country (2020-2025) & (M USD)
Table 52. Middle East and Africa Oncolytic Virus Manufacturing Services Sales by Region (2020-2025) & (K Units)
Table 53. Middle East and Africa Oncolytic Virus Manufacturing Services Market Size by Region (2020-2025) & (M USD)
Table 54. Global Oncolytic Virus Manufacturing Services Production (K Units) by Region(2020-2025)
Table 55. Global Oncolytic Virus Manufacturing Services Revenue (US$ Million) by Region (2020-2025)
Table 56. Global Oncolytic Virus Manufacturing Services Revenue Market Share by Region (2020-2025)
Table 57. Global Oncolytic Virus Manufacturing Services Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 58. North America Oncolytic Virus Manufacturing Services Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 59. Europe Oncolytic Virus Manufacturing Services Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 60. Japan Oncolytic Virus Manufacturing Services Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 61. China Oncolytic Virus Manufacturing Services Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 62. Recipharm (Vibalogics) Basic Information
Table 63. Recipharm (Vibalogics) Oncolytic Virus Manufacturing Services Product Overview
Table 64. Recipharm (Vibalogics) Oncolytic Virus Manufacturing Services Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 65. Recipharm (Vibalogics) Business Overview
Table 66. Recipharm (Vibalogics) SWOT Analysis
Table 67. Recipharm (Vibalogics) Recent Developments
Table 68. IDT Biologika Basic Information
Table 69. IDT Biologika Oncolytic Virus Manufacturing Services Product Overview
Table 70. IDT Biologika Oncolytic Virus Manufacturing Services Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 71. IDT Biologika Business Overview
Table 72. IDT Biologika SWOT Analysis
Table 73. IDT Biologika Recent Developments
Table 74. FUJIFILM Diosynth Biotechnologies Basic Information
Table 75. FUJIFILM Diosynth Biotechnologies Oncolytic Virus Manufacturing Services Product Overview
Table 76. FUJIFILM Diosynth Biotechnologies Oncolytic Virus Manufacturing Services Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 77. FUJIFILM Diosynth Biotechnologies Business Overview
Table 78. FUJIFILM Diosynth Biotechnologies SWOT Analysis
Table 79. FUJIFILM Diosynth Biotechnologies Recent Developments
Table 80. Exothera Basic Information
Table 81. Exothera Oncolytic Virus Manufacturing Services Product Overview
Table 82. Exothera Oncolytic Virus Manufacturing Services Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 83. Exothera Business Overview
Table 84. Exothera Recent Developments
Table 85. Lonza Basic Information
Table 86. Lonza Oncolytic Virus Manufacturing Services Product Overview
Table 87. Lonza Oncolytic Virus Manufacturing Services Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 88. Lonza Business Overview
Table 89. Lonza Recent Developments
Table 90. Creative Biolabs Basic Information
Table 91. Creative Biolabs Oncolytic Virus Manufacturing Services Product Overview
Table 92. Creative Biolabs Oncolytic Virus Manufacturing Services Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 93. Creative Biolabs Business Overview
Table 94. Creative Biolabs Recent Developments
Table 95. Takara Bio Basic Information
Table 96. Takara Bio Oncolytic Virus Manufacturing Services Product Overview
Table 97. Takara Bio Oncolytic Virus Manufacturing Services Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 98. Takara Bio Business Overview
Table 99. Takara Bio Recent Developments
Table 100. Libentech Basic Information
Table 101. Libentech Oncolytic Virus Manufacturing Services Product Overview
Table 102. Libentech Oncolytic Virus Manufacturing Services Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 103. Libentech Business Overview
Table 104. Libentech Recent Developments
Table 105. ABL Basic Information
Table 106. ABL Oncolytic Virus Manufacturing Services Product Overview
Table 107. ABL Oncolytic Virus Manufacturing Services Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 108. ABL Business Overview
Table 109. ABL Recent Developments
Table 110. Nabios Basic Information
Table 111. Nabios Oncolytic Virus Manufacturing Services Product Overview
Table 112. Nabios Oncolytic Virus Manufacturing Services Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 113. Nabios Business Overview
Table 114. Nabios Recent Developments
Table 115. Halix Basic Information
Table 116. Halix Oncolytic Virus Manufacturing Services Product Overview
Table 117. Halix Oncolytic Virus Manufacturing Services Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 118. Halix Business Overview
Table 119. Halix Recent Developments
Table 120. Obio Technology Basic Information
Table 121. Obio Technology Oncolytic Virus Manufacturing Services Product Overview
Table 122. Obio Technology Oncolytic Virus Manufacturing Services Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 123. Obio Technology Business Overview
Table 124. Obio Technology Recent Developments
Table 125. Porton Advanced Basic Information
Table 126. Porton Advanced Oncolytic Virus Manufacturing Services Product Overview
Table 127. Porton Advanced Oncolytic Virus Manufacturing Services Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 128. Porton Advanced Business Overview
Table 129. Porton Advanced Recent Developments
Table 130. WuXi ATU Basic Information
Table 131. WuXi ATU Oncolytic Virus Manufacturing Services Product Overview
Table 132. WuXi ATU Oncolytic Virus Manufacturing Services Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 133. WuXi ATU Business Overview
Table 134. WuXi ATU Recent Developments
Table 135. Genevoyager Basic Information
Table 136. Genevoyager Oncolytic Virus Manufacturing Services Product Overview
Table 137. Genevoyager Oncolytic Virus Manufacturing Services Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 138. Genevoyager Business Overview
Table 139. Genevoyager Recent Developments
Table 140. Global Oncolytic Virus Manufacturing Services Sales Forecast by Region (2026-2035) & (K Units)
Table 141. Global Oncolytic Virus Manufacturing Services Market Size Forecast by Region (2026-2035) & (M USD)
Table 142. North America Oncolytic Virus Manufacturing Services Sales Forecast by Country (2026-2035) & (K Units)
Table 143. North America Oncolytic Virus Manufacturing Services Market Size Forecast by Country (2026-2035) & (M USD)
Table 144. Europe Oncolytic Virus Manufacturing Services Sales Forecast by Country (2026-2035) & (K Units)
Table 145. Europe Oncolytic Virus Manufacturing Services Market Size Forecast by Country (2026-2035) & (M USD)
Table 146. Asia Pacific Oncolytic Virus Manufacturing Services Sales Forecast by Region (2026-2035) & (K Units)
Table 147. Asia Pacific Oncolytic Virus Manufacturing Services Market Size Forecast by Region (2026-2035) & (M USD)
Table 148. South America Oncolytic Virus Manufacturing Services Sales Forecast by Country (2026-2035) & (K Units)
Table 149. South America Oncolytic Virus Manufacturing Services Market Size Forecast by Country (2026-2035) & (M USD)
Table 150. Middle East and Africa Oncolytic Virus Manufacturing Services Sales Forecast by Country (2026-2035) & (Units)
Table 151. Middle East and Africa Oncolytic Virus Manufacturing Services Market Size Forecast by Country (2026-2035) & (M USD)
Table 152. Global Oncolytic Virus Manufacturing Services Sales Forecast by Type (2026-2035) & (K Units)
Table 153. Global Oncolytic Virus Manufacturing Services Market Size Forecast by Type (2026-2035) & (M USD)
Table 154. Global Oncolytic Virus Manufacturing Services Price Forecast by Type (2026-2035) & (USD/Unit)
Table 155. Global Oncolytic Virus Manufacturing Services Sales (K Units) Forecast by Application (2026-2035)
Table 156. Global Oncolytic Virus Manufacturing Services Market Size Forecast by Application (2026-2035) & (M USD)
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Global Oncolytic Virus Manufacturing Services Market Size by Type (M USD)
Table 4. Global Oncolytic Virus Manufacturing Services Market Size by Application
Table 5. Oncolytic Virus Manufacturing Services Market Size Comparison by Region (M USD)
Table 6. Global Oncolytic Virus Manufacturing Services Sales (K Units) by Manufacturers (2020-2025)
Table 7. Global Oncolytic Virus Manufacturing Services Sales Market Share by Manufacturers (2020-2025)
Table 8. Global Oncolytic Virus Manufacturing Services Revenue (M USD) by Manufacturers (2020-2025)
Table 9. Global Oncolytic Virus Manufacturing Services Revenue Share by Manufacturers (2020-2025)
Table 10. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Oncolytic Virus Manufacturing Services as of 2025)
Table 11. Global Market Oncolytic Virus Manufacturing Services Average Price (USD/Unit) of Key Manufacturers (2020-2025)
Table 12. Manufacturers? Manufacturing Sites, Areas Served
Table 13. Manufacturers? Product Type
Table 14. Global Oncolytic Virus Manufacturing Services Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 15. Mergers & Acquisitions, Expansion Plans
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Oncolytic Virus Manufacturing Services Market Challenges
Table 22. Goldman Sachs' forecast real GDP growth rate for 2025-2026
Table 23. S&P Global ' Forecast Real GDP Growth Rate For 2025-2027
Table 24. World Bank ' Forecast Real GDP Growth Rate For 2025-2026
Table 25. The Tariff Rates Imposed by the United States on Major Commodity Trading Countries
Table 26. Global Oncolytic Virus Manufacturing Services Sales by Type (K Units)
Table 27. Global Oncolytic Virus Manufacturing Services Market Size by Type (M USD)
Table 28. Global Oncolytic Virus Manufacturing Services Sales (K Units) by Type (2020-2025)
Table 29. Global Oncolytic Virus Manufacturing Services Sales Market Share by Type (2020-2025)
Table 30. Global Oncolytic Virus Manufacturing Services Market Size (M USD) by Type (2020-2025)
Table 31. Global Oncolytic Virus Manufacturing Services Market Share by Type (2020-2025)
Table 32. Global Oncolytic Virus Manufacturing Services Price (USD/Unit) by Type (2020-2025)
Table 33. Global Oncolytic Virus Manufacturing Services Sales (K Units) by Application
Table 34. Global Oncolytic Virus Manufacturing Services Market Size by Application
Table 35. Global Oncolytic Virus Manufacturing Services Sales by Application (2020-2025) & (K Units)
Table 36. Global Oncolytic Virus Manufacturing Services Sales Market Share by Application (2020-2025)
Table 37. Global Oncolytic Virus Manufacturing Services Market Size by Application (2020-2025) & (M USD)
Table 38. Global Oncolytic Virus Manufacturing Services Market Share by Application (2020-2025)
Table 39. Global Oncolytic Virus Manufacturing Services Sales Growth Rate by Application (2020-2025)
Table 40. Global Oncolytic Virus Manufacturing Services Sales by Region (2020-2025) & (K Units)
Table 41. Global Oncolytic Virus Manufacturing Services Sales Market Share by Region (2020-2025)
Table 42. Global Oncolytic Virus Manufacturing Services Market Size by Region (2020-2025) & (M USD)
Table 43. Global Oncolytic Virus Manufacturing Services Market Size by Region (2020-2025)
Table 44. North America Oncolytic Virus Manufacturing Services Sales by Country (2020-2025) & (K Units)
Table 45. North America Oncolytic Virus Manufacturing Services Market Size by Country (2020-2025) & (M USD)
Table 46. Europe Oncolytic Virus Manufacturing Services Sales by Country (2020-2025) & (K Units)
Table 47. Europe Oncolytic Virus Manufacturing Services Market Size by Country (2020-2025) & (M USD)
Table 48. Asia Pacific Oncolytic Virus Manufacturing Services Sales by Region (2020-2025) & (K Units)
Table 49. Asia Pacific Oncolytic Virus Manufacturing Services Market Size by Region (2020-2025) & (M USD)
Table 50. South America Oncolytic Virus Manufacturing Services Sales by Country (2020-2025) & (K Units)
Table 51. South America Oncolytic Virus Manufacturing Services Market Size by Country (2020-2025) & (M USD)
Table 52. Middle East and Africa Oncolytic Virus Manufacturing Services Sales by Region (2020-2025) & (K Units)
Table 53. Middle East and Africa Oncolytic Virus Manufacturing Services Market Size by Region (2020-2025) & (M USD)
Table 54. Global Oncolytic Virus Manufacturing Services Production (K Units) by Region(2020-2025)
Table 55. Global Oncolytic Virus Manufacturing Services Revenue (US$ Million) by Region (2020-2025)
Table 56. Global Oncolytic Virus Manufacturing Services Revenue Market Share by Region (2020-2025)
Table 57. Global Oncolytic Virus Manufacturing Services Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 58. North America Oncolytic Virus Manufacturing Services Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 59. Europe Oncolytic Virus Manufacturing Services Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 60. Japan Oncolytic Virus Manufacturing Services Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 61. China Oncolytic Virus Manufacturing Services Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 62. Recipharm (Vibalogics) Basic Information
Table 63. Recipharm (Vibalogics) Oncolytic Virus Manufacturing Services Product Overview
Table 64. Recipharm (Vibalogics) Oncolytic Virus Manufacturing Services Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 65. Recipharm (Vibalogics) Business Overview
Table 66. Recipharm (Vibalogics) SWOT Analysis
Table 67. Recipharm (Vibalogics) Recent Developments
Table 68. IDT Biologika Basic Information
Table 69. IDT Biologika Oncolytic Virus Manufacturing Services Product Overview
Table 70. IDT Biologika Oncolytic Virus Manufacturing Services Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 71. IDT Biologika Business Overview
Table 72. IDT Biologika SWOT Analysis
Table 73. IDT Biologika Recent Developments
Table 74. FUJIFILM Diosynth Biotechnologies Basic Information
Table 75. FUJIFILM Diosynth Biotechnologies Oncolytic Virus Manufacturing Services Product Overview
Table 76. FUJIFILM Diosynth Biotechnologies Oncolytic Virus Manufacturing Services Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 77. FUJIFILM Diosynth Biotechnologies Business Overview
Table 78. FUJIFILM Diosynth Biotechnologies SWOT Analysis
Table 79. FUJIFILM Diosynth Biotechnologies Recent Developments
Table 80. Exothera Basic Information
Table 81. Exothera Oncolytic Virus Manufacturing Services Product Overview
Table 82. Exothera Oncolytic Virus Manufacturing Services Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 83. Exothera Business Overview
Table 84. Exothera Recent Developments
Table 85. Lonza Basic Information
Table 86. Lonza Oncolytic Virus Manufacturing Services Product Overview
Table 87. Lonza Oncolytic Virus Manufacturing Services Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 88. Lonza Business Overview
Table 89. Lonza Recent Developments
Table 90. Creative Biolabs Basic Information
Table 91. Creative Biolabs Oncolytic Virus Manufacturing Services Product Overview
Table 92. Creative Biolabs Oncolytic Virus Manufacturing Services Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 93. Creative Biolabs Business Overview
Table 94. Creative Biolabs Recent Developments
Table 95. Takara Bio Basic Information
Table 96. Takara Bio Oncolytic Virus Manufacturing Services Product Overview
Table 97. Takara Bio Oncolytic Virus Manufacturing Services Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 98. Takara Bio Business Overview
Table 99. Takara Bio Recent Developments
Table 100. Libentech Basic Information
Table 101. Libentech Oncolytic Virus Manufacturing Services Product Overview
Table 102. Libentech Oncolytic Virus Manufacturing Services Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 103. Libentech Business Overview
Table 104. Libentech Recent Developments
Table 105. ABL Basic Information
Table 106. ABL Oncolytic Virus Manufacturing Services Product Overview
Table 107. ABL Oncolytic Virus Manufacturing Services Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 108. ABL Business Overview
Table 109. ABL Recent Developments
Table 110. Nabios Basic Information
Table 111. Nabios Oncolytic Virus Manufacturing Services Product Overview
Table 112. Nabios Oncolytic Virus Manufacturing Services Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 113. Nabios Business Overview
Table 114. Nabios Recent Developments
Table 115. Halix Basic Information
Table 116. Halix Oncolytic Virus Manufacturing Services Product Overview
Table 117. Halix Oncolytic Virus Manufacturing Services Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 118. Halix Business Overview
Table 119. Halix Recent Developments
Table 120. Obio Technology Basic Information
Table 121. Obio Technology Oncolytic Virus Manufacturing Services Product Overview
Table 122. Obio Technology Oncolytic Virus Manufacturing Services Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 123. Obio Technology Business Overview
Table 124. Obio Technology Recent Developments
Table 125. Porton Advanced Basic Information
Table 126. Porton Advanced Oncolytic Virus Manufacturing Services Product Overview
Table 127. Porton Advanced Oncolytic Virus Manufacturing Services Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 128. Porton Advanced Business Overview
Table 129. Porton Advanced Recent Developments
Table 130. WuXi ATU Basic Information
Table 131. WuXi ATU Oncolytic Virus Manufacturing Services Product Overview
Table 132. WuXi ATU Oncolytic Virus Manufacturing Services Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 133. WuXi ATU Business Overview
Table 134. WuXi ATU Recent Developments
Table 135. Genevoyager Basic Information
Table 136. Genevoyager Oncolytic Virus Manufacturing Services Product Overview
Table 137. Genevoyager Oncolytic Virus Manufacturing Services Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 138. Genevoyager Business Overview
Table 139. Genevoyager Recent Developments
Table 140. Global Oncolytic Virus Manufacturing Services Sales Forecast by Region (2026-2035) & (K Units)
Table 141. Global Oncolytic Virus Manufacturing Services Market Size Forecast by Region (2026-2035) & (M USD)
Table 142. North America Oncolytic Virus Manufacturing Services Sales Forecast by Country (2026-2035) & (K Units)
Table 143. North America Oncolytic Virus Manufacturing Services Market Size Forecast by Country (2026-2035) & (M USD)
Table 144. Europe Oncolytic Virus Manufacturing Services Sales Forecast by Country (2026-2035) & (K Units)
Table 145. Europe Oncolytic Virus Manufacturing Services Market Size Forecast by Country (2026-2035) & (M USD)
Table 146. Asia Pacific Oncolytic Virus Manufacturing Services Sales Forecast by Region (2026-2035) & (K Units)
Table 147. Asia Pacific Oncolytic Virus Manufacturing Services Market Size Forecast by Region (2026-2035) & (M USD)
Table 148. South America Oncolytic Virus Manufacturing Services Sales Forecast by Country (2026-2035) & (K Units)
Table 149. South America Oncolytic Virus Manufacturing Services Market Size Forecast by Country (2026-2035) & (M USD)
Table 150. Middle East and Africa Oncolytic Virus Manufacturing Services Sales Forecast by Country (2026-2035) & (Units)
Table 151. Middle East and Africa Oncolytic Virus Manufacturing Services Market Size Forecast by Country (2026-2035) & (M USD)
Table 152. Global Oncolytic Virus Manufacturing Services Sales Forecast by Type (2026-2035) & (K Units)
Table 153. Global Oncolytic Virus Manufacturing Services Market Size Forecast by Type (2026-2035) & (M USD)
Table 154. Global Oncolytic Virus Manufacturing Services Price Forecast by Type (2026-2035) & (USD/Unit)
Table 155. Global Oncolytic Virus Manufacturing Services Sales (K Units) Forecast by Application (2026-2035)
Table 156. Global Oncolytic Virus Manufacturing Services Market Size Forecast by Application (2026-2035) & (M USD)
LIST OF FIGURES
Figure 1. Product Picture of Oncolytic Virus Manufacturing Services
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Oncolytic Virus Manufacturing Services Market Size (M USD), 2025-2035
Figure 5. Global Oncolytic Virus Manufacturing Services Market Size (M USD) (2020-2035)
Figure 6. Global Oncolytic Virus Manufacturing Services Sales (K Units) & (2020-2035)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Oncolytic Virus Manufacturing Services Market Size by Country (M USD)
Figure 11. Company Assessment Quadrant
Figure 12. Global Oncolytic Virus Manufacturing Services Product Life Cycle
Figure 13. Oncolytic Virus Manufacturing Services Sales Share by Manufacturers in 2025
Figure 14. Global Oncolytic Virus Manufacturing Services Revenue Share by Manufacturers in 2025
Figure 15. Oncolytic Virus Manufacturing Services Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2025
Figure 16. Global Market Oncolytic Virus Manufacturing Services Average Price (USD/Unit) of Key Manufacturers in 2025
Figure 17. The Global 5 and 10 Largest Players: Market Share by Oncolytic Virus Manufacturing Services Revenue in 2025
Figure 18. Industry Chain Map of Oncolytic Virus Manufacturing Services
Figure 19. Global Oncolytic Virus Manufacturing Services Market PEST Analysis
Figure 20. Global Oncolytic Virus Manufacturing Services Market Porter's Five Forces Analysis
Figure 21. Global Merchandise Trade as a Percentage Of GDP
Figure 22. US - lmports of Goods by Country
Figure 23. China Exports by Country
Figure 24. ESG Rating Distribution of The Leading Company Compared With Its Peers
Figure 25. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 26. Global Oncolytic Virus Manufacturing Services Market Share by Type
Figure 27. Sales Market Share of Oncolytic Virus Manufacturing Services by Type (2020-2025)
Figure 28. Sales Market Share of Oncolytic Virus Manufacturing Services by Type in 2025
Figure 29. Market Share of Oncolytic Virus Manufacturing Services by Type (2020-2025)
Figure 30. Market Share of Oncolytic Virus Manufacturing Services by Type in 2025
Figure 31. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 32. Global Oncolytic Virus Manufacturing Services Market Share by Application
Figure 33. Global Oncolytic Virus Manufacturing Services Sales Market Share by Application (2020-2025)
Figure 34. Global Oncolytic Virus Manufacturing Services Sales Market Share by Application in 2025
Figure 35. Global Oncolytic Virus Manufacturing Services Market Share by Application (2020-2025)
Figure 36. Global Oncolytic Virus Manufacturing Services Market Share by Application in 2025
Figure 37. Global Oncolytic Virus Manufacturing Services Sales Growth Rate by Application (2020-2025)
Figure 38. Global Oncolytic Virus Manufacturing Services Sales Market Share by Region (2020-2025)
Figure 39. Global Oncolytic Virus Manufacturing Services Market Size by Region (2020-2025)
Figure 40. North America Oncolytic Virus Manufacturing Services Sales and Growth Rate (2020-2025) & (K Units)
Figure 41. North America Oncolytic Virus Manufacturing Services Sales and Growth Rate (2020-2025) & (K Units)
Figure 42. North America Oncolytic Virus Manufacturing Services Sales Market Share by Country in 2024
Figure 43. North America Oncolytic Virus Manufacturing Services Market Size and Growth Rate (2020-2025) & (M USD)
Figure 44. North America Oncolytic Virus Manufacturing Services Market Size by Country in 2024
Figure 45. U.S. Oncolytic Virus Manufacturing Services Sales and Growth Rate (2020-2025) & (K Units)
Figure 46. U.S. Oncolytic Virus Manufacturing Services Market Size and Growth Rate (2020-2025) & (M USD)
Figure 47. Canada Oncolytic Virus Manufacturing Services Sales (K Units) and Growth Rate (2020-2025)
Figure 48. Canada Oncolytic Virus Manufacturing Services Market Size (M USD) and Growth Rate (2020-2025)
Figure 49. Mexico Oncolytic Virus Manufacturing Services Sales (Units) and Growth Rate (2020-2025)
Figure 50. Mexico Oncolytic Virus Manufacturing Services Market Size (Units) and Growth Rate (2020-2025)
Figure 51. Europe Oncolytic Virus Manufacturing Services Sales and Growth Rate (2020-2025) & (K Units)
Figure 52. Europe Oncolytic Virus Manufacturing Services Sales Market Share by Country in 2024
Figure 53. Europe Oncolytic Virus Manufacturing Services Market Size and Growth Rate (2020-2025) & (M USD)
Figure 54. Europe Oncolytic Virus Manufacturing Services Market Size by Country in 2024
Figure 55. Germany Oncolytic Virus Manufacturing Services Sales and Growth Rate (2020-2025) & (K Units)
Figure 56. Germany Oncolytic Virus Manufacturing Services Market Size and Growth Rate (2020-2025) & (M USD)
Figure 57. France Oncolytic Virus Manufacturing Services Sales and Growth Rate (2020-2025) & (K Units)
Figure 58. France Oncolytic Virus Manufacturing Services Market Size and Growth Rate (2020-2025) & (M USD)
Figure 59. U.K. Oncolytic Virus Manufacturing Services Sales and Growth Rate (2020-2025) & (K Units)
Figure 60. U.K. Oncolytic Virus Manufacturing Services Market Size and Growth Rate (2020-2025) & (M USD)
Figure 61. Italy Oncolytic Virus Manufacturing Services Sales and Growth Rate (2020-2025) & (K Units)
Figure 62. Italy Oncolytic Virus Manufacturing Services Market Size and Growth Rate (2020-2025) & (M USD)
Figure 63. Spain Oncolytic Virus Manufacturing Services Sales and Growth Rate (2020-2025) & (K Units)
Figure 64. Spain Oncolytic Virus Manufacturing Services Market Size and Growth Rate (2020-2025) & (M USD)
Figure 65. Asia Pacific Oncolytic Virus Manufacturing Services Sales and Growth Rate (K Units)
Figure 66. Asia Pacific Oncolytic Virus Manufacturing Services Sales Market Share by Region in 2024
Figure 67. Asia Pacific Oncolytic Virus Manufacturing Services Market Size by Region in 2024
Figure 68. China Oncolytic Virus Manufacturing Services Sales and Growth Rate (2020-2025) & (K Units)
Figure 69. China Oncolytic Virus Manufacturing Services Market Size and Growth Rate (2020-2025) & (M USD)
Figure 70. Japan Oncolytic Virus Manufacturing Services Sales and Growth Rate (2020-2025) & (K Units)
Figure 71. Japan Oncolytic Virus Manufacturing Services Market Size and Growth Rate (2020-2025) & (M USD)
Figure 72. South Korea Oncolytic Virus Manufacturing Services Sales and Growth Rate (2020-2025) & (K Units)
Figure 73. South Korea Oncolytic Virus Manufacturing Services Market Size and Growth Rate (2020-2025) & (M USD)
Figure 74. India Oncolytic Virus Manufacturing Services Sales and Growth Rate (2020-2025) & (K Units)
Figure 75. India Oncolytic Virus Manufacturing Services Market Size and Growth Rate (2020-2025) & (M USD)
Figure 76. Southeast Asia Oncolytic Virus Manufacturing Services Sales and Growth Rate (2020-2025) & (K Units)
Figure 77. Southeast Asia Oncolytic Virus Manufacturing Services Market Size and Growth Rate (2020-2025) & (M USD)
Figure 78. South America Oncolytic Virus Manufacturing Services Sales and Growth Rate (K Units)
Figure 79. South America Oncolytic Virus Manufacturing Services Sales Market Share by Country in 2024
Figure 80. South America Oncolytic Virus Manufacturing Services Market Size and Growth Rate (M USD)
Figure 81. South America Oncolytic Virus Manufacturing Services Market Size by Country in 2024
Figure 82. Brazil Oncolytic Virus Manufacturing Services Sales and Growth Rate (2020-2025) & (K Units)
Figure 83. Brazil Oncolytic Virus Manufacturing Services Market Size and Growth Rate (2020-2025) & (M USD)
Figure 84. Argentina Oncolytic Virus Manufacturing Services Sales and Growth Rate (2020-2025) & (K Units)
Figure 85. Argentina Oncolytic Virus Manufacturing Services Market Size and Growth Rate (2020-2025) & (M USD)
Figure 86. Columbia Oncolytic Virus Manufacturing Services Sales and Growth Rate (2020-2025) & (K Units)
Figure 87. Columbia Oncolytic Virus Manufacturing Services Market Size and Growth Rate (2020-2025) & (M USD)
Figure 88. Middle East and Africa Oncolytic Virus Manufacturing Services Sales and Growth Rate (K Units)
Figure 89. Middle East and Africa Oncolytic Virus Manufacturing Services Sales Market Share by Region in 2024
Figure 90. Middle East and Africa Oncolytic Virus Manufacturing Services Market Size and Growth Rate (M USD)
Figure 91. Middle East and Africa Oncolytic Virus Manufacturing Services Market Size by Region in 2024
Figure 92. Saudi Arabia Oncolytic Virus Manufacturing Services Sales and Growth Rate (2020-2025) & (K Units)
Figure 93. Saudi Arabia Oncolytic Virus Manufacturing Services Market Size and Growth Rate (2020-2025) & (M USD)
Figure 94. UAE Oncolytic Virus Manufacturing Services Sales and Growth Rate (2020-2025) & (K Units)
Figure 95. UAE Oncolytic Virus Manufacturing Services Market Size and Growth Rate (2020-2025) & (M USD)
Figure 96. Egypt Oncolytic Virus Manufacturing Services Sales and Growth Rate (2020-2025) & (K Units)
Figure 97. Egypt Oncolytic Virus Manufacturing Services Market Size and Growth Rate (2020-2025) & (M USD)
Figure 98. Nigeria Oncolytic Virus Manufacturing Services Sales and Growth Rate (2020-2025) & (K Units)
Figure 99. Nigeria Oncolytic Virus Manufacturing Services Market Size and Growth Rate (2020-2025) & (M USD)
Figure 100. South Africa Oncolytic Virus Manufacturing Services Sales and Growth Rate (2020-2025) & (K Units)
Figure 101. South Africa Oncolytic Virus Manufacturing Services Market Size and Growth Rate (2020-2025) & (M USD)
Figure 102. Global Oncolytic Virus Manufacturing Services Production Market Share by Region (2020-2025)
Figure 103. North America Oncolytic Virus Manufacturing Services Production (K Units) Growth Rate (2020-2025)
Figure 104. Europe Oncolytic Virus Manufacturing Services Production (K Units) Growth Rate (2020-2025)
Figure 105. Japan Oncolytic Virus Manufacturing Services Production (K Units) Growth Rate (2020-2025)
Figure 106. China Oncolytic Virus Manufacturing Services Production (K Units) Growth Rate (2020-2025)
Figure 107. Global Oncolytic Virus Manufacturing Services Sales Forecast by Volume (2020-2035) & (K Units)
Figure 108. Global Oncolytic Virus Manufacturing Services Market Size Forecast by Value (2020-2035) & (M USD)
Figure 109. Global Oncolytic Virus Manufacturing Services Sales Market Share Forecast by Type (2026-2035)
Figure 110. Global Oncolytic Virus Manufacturing Services Market Share Forecast by Type (2026-2035)
Figure 111. Global Oncolytic Virus Manufacturing Services Sales Forecast by Application (2026-2035)
Figure 112. Global Oncolytic Virus Manufacturing Services Market Share Forecast by Application (2026-2035)
Figure 1. Product Picture of Oncolytic Virus Manufacturing Services
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Oncolytic Virus Manufacturing Services Market Size (M USD), 2025-2035
Figure 5. Global Oncolytic Virus Manufacturing Services Market Size (M USD) (2020-2035)
Figure 6. Global Oncolytic Virus Manufacturing Services Sales (K Units) & (2020-2035)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Oncolytic Virus Manufacturing Services Market Size by Country (M USD)
Figure 11. Company Assessment Quadrant
Figure 12. Global Oncolytic Virus Manufacturing Services Product Life Cycle
Figure 13. Oncolytic Virus Manufacturing Services Sales Share by Manufacturers in 2025
Figure 14. Global Oncolytic Virus Manufacturing Services Revenue Share by Manufacturers in 2025
Figure 15. Oncolytic Virus Manufacturing Services Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2025
Figure 16. Global Market Oncolytic Virus Manufacturing Services Average Price (USD/Unit) of Key Manufacturers in 2025
Figure 17. The Global 5 and 10 Largest Players: Market Share by Oncolytic Virus Manufacturing Services Revenue in 2025
Figure 18. Industry Chain Map of Oncolytic Virus Manufacturing Services
Figure 19. Global Oncolytic Virus Manufacturing Services Market PEST Analysis
Figure 20. Global Oncolytic Virus Manufacturing Services Market Porter's Five Forces Analysis
Figure 21. Global Merchandise Trade as a Percentage Of GDP
Figure 22. US - lmports of Goods by Country
Figure 23. China Exports by Country
Figure 24. ESG Rating Distribution of The Leading Company Compared With Its Peers
Figure 25. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 26. Global Oncolytic Virus Manufacturing Services Market Share by Type
Figure 27. Sales Market Share of Oncolytic Virus Manufacturing Services by Type (2020-2025)
Figure 28. Sales Market Share of Oncolytic Virus Manufacturing Services by Type in 2025
Figure 29. Market Share of Oncolytic Virus Manufacturing Services by Type (2020-2025)
Figure 30. Market Share of Oncolytic Virus Manufacturing Services by Type in 2025
Figure 31. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 32. Global Oncolytic Virus Manufacturing Services Market Share by Application
Figure 33. Global Oncolytic Virus Manufacturing Services Sales Market Share by Application (2020-2025)
Figure 34. Global Oncolytic Virus Manufacturing Services Sales Market Share by Application in 2025
Figure 35. Global Oncolytic Virus Manufacturing Services Market Share by Application (2020-2025)
Figure 36. Global Oncolytic Virus Manufacturing Services Market Share by Application in 2025
Figure 37. Global Oncolytic Virus Manufacturing Services Sales Growth Rate by Application (2020-2025)
Figure 38. Global Oncolytic Virus Manufacturing Services Sales Market Share by Region (2020-2025)
Figure 39. Global Oncolytic Virus Manufacturing Services Market Size by Region (2020-2025)
Figure 40. North America Oncolytic Virus Manufacturing Services Sales and Growth Rate (2020-2025) & (K Units)
Figure 41. North America Oncolytic Virus Manufacturing Services Sales and Growth Rate (2020-2025) & (K Units)
Figure 42. North America Oncolytic Virus Manufacturing Services Sales Market Share by Country in 2024
Figure 43. North America Oncolytic Virus Manufacturing Services Market Size and Growth Rate (2020-2025) & (M USD)
Figure 44. North America Oncolytic Virus Manufacturing Services Market Size by Country in 2024
Figure 45. U.S. Oncolytic Virus Manufacturing Services Sales and Growth Rate (2020-2025) & (K Units)
Figure 46. U.S. Oncolytic Virus Manufacturing Services Market Size and Growth Rate (2020-2025) & (M USD)
Figure 47. Canada Oncolytic Virus Manufacturing Services Sales (K Units) and Growth Rate (2020-2025)
Figure 48. Canada Oncolytic Virus Manufacturing Services Market Size (M USD) and Growth Rate (2020-2025)
Figure 49. Mexico Oncolytic Virus Manufacturing Services Sales (Units) and Growth Rate (2020-2025)
Figure 50. Mexico Oncolytic Virus Manufacturing Services Market Size (Units) and Growth Rate (2020-2025)
Figure 51. Europe Oncolytic Virus Manufacturing Services Sales and Growth Rate (2020-2025) & (K Units)
Figure 52. Europe Oncolytic Virus Manufacturing Services Sales Market Share by Country in 2024
Figure 53. Europe Oncolytic Virus Manufacturing Services Market Size and Growth Rate (2020-2025) & (M USD)
Figure 54. Europe Oncolytic Virus Manufacturing Services Market Size by Country in 2024
Figure 55. Germany Oncolytic Virus Manufacturing Services Sales and Growth Rate (2020-2025) & (K Units)
Figure 56. Germany Oncolytic Virus Manufacturing Services Market Size and Growth Rate (2020-2025) & (M USD)
Figure 57. France Oncolytic Virus Manufacturing Services Sales and Growth Rate (2020-2025) & (K Units)
Figure 58. France Oncolytic Virus Manufacturing Services Market Size and Growth Rate (2020-2025) & (M USD)
Figure 59. U.K. Oncolytic Virus Manufacturing Services Sales and Growth Rate (2020-2025) & (K Units)
Figure 60. U.K. Oncolytic Virus Manufacturing Services Market Size and Growth Rate (2020-2025) & (M USD)
Figure 61. Italy Oncolytic Virus Manufacturing Services Sales and Growth Rate (2020-2025) & (K Units)
Figure 62. Italy Oncolytic Virus Manufacturing Services Market Size and Growth Rate (2020-2025) & (M USD)
Figure 63. Spain Oncolytic Virus Manufacturing Services Sales and Growth Rate (2020-2025) & (K Units)
Figure 64. Spain Oncolytic Virus Manufacturing Services Market Size and Growth Rate (2020-2025) & (M USD)
Figure 65. Asia Pacific Oncolytic Virus Manufacturing Services Sales and Growth Rate (K Units)
Figure 66. Asia Pacific Oncolytic Virus Manufacturing Services Sales Market Share by Region in 2024
Figure 67. Asia Pacific Oncolytic Virus Manufacturing Services Market Size by Region in 2024
Figure 68. China Oncolytic Virus Manufacturing Services Sales and Growth Rate (2020-2025) & (K Units)
Figure 69. China Oncolytic Virus Manufacturing Services Market Size and Growth Rate (2020-2025) & (M USD)
Figure 70. Japan Oncolytic Virus Manufacturing Services Sales and Growth Rate (2020-2025) & (K Units)
Figure 71. Japan Oncolytic Virus Manufacturing Services Market Size and Growth Rate (2020-2025) & (M USD)
Figure 72. South Korea Oncolytic Virus Manufacturing Services Sales and Growth Rate (2020-2025) & (K Units)
Figure 73. South Korea Oncolytic Virus Manufacturing Services Market Size and Growth Rate (2020-2025) & (M USD)
Figure 74. India Oncolytic Virus Manufacturing Services Sales and Growth Rate (2020-2025) & (K Units)
Figure 75. India Oncolytic Virus Manufacturing Services Market Size and Growth Rate (2020-2025) & (M USD)
Figure 76. Southeast Asia Oncolytic Virus Manufacturing Services Sales and Growth Rate (2020-2025) & (K Units)
Figure 77. Southeast Asia Oncolytic Virus Manufacturing Services Market Size and Growth Rate (2020-2025) & (M USD)
Figure 78. South America Oncolytic Virus Manufacturing Services Sales and Growth Rate (K Units)
Figure 79. South America Oncolytic Virus Manufacturing Services Sales Market Share by Country in 2024
Figure 80. South America Oncolytic Virus Manufacturing Services Market Size and Growth Rate (M USD)
Figure 81. South America Oncolytic Virus Manufacturing Services Market Size by Country in 2024
Figure 82. Brazil Oncolytic Virus Manufacturing Services Sales and Growth Rate (2020-2025) & (K Units)
Figure 83. Brazil Oncolytic Virus Manufacturing Services Market Size and Growth Rate (2020-2025) & (M USD)
Figure 84. Argentina Oncolytic Virus Manufacturing Services Sales and Growth Rate (2020-2025) & (K Units)
Figure 85. Argentina Oncolytic Virus Manufacturing Services Market Size and Growth Rate (2020-2025) & (M USD)
Figure 86. Columbia Oncolytic Virus Manufacturing Services Sales and Growth Rate (2020-2025) & (K Units)
Figure 87. Columbia Oncolytic Virus Manufacturing Services Market Size and Growth Rate (2020-2025) & (M USD)
Figure 88. Middle East and Africa Oncolytic Virus Manufacturing Services Sales and Growth Rate (K Units)
Figure 89. Middle East and Africa Oncolytic Virus Manufacturing Services Sales Market Share by Region in 2024
Figure 90. Middle East and Africa Oncolytic Virus Manufacturing Services Market Size and Growth Rate (M USD)
Figure 91. Middle East and Africa Oncolytic Virus Manufacturing Services Market Size by Region in 2024
Figure 92. Saudi Arabia Oncolytic Virus Manufacturing Services Sales and Growth Rate (2020-2025) & (K Units)
Figure 93. Saudi Arabia Oncolytic Virus Manufacturing Services Market Size and Growth Rate (2020-2025) & (M USD)
Figure 94. UAE Oncolytic Virus Manufacturing Services Sales and Growth Rate (2020-2025) & (K Units)
Figure 95. UAE Oncolytic Virus Manufacturing Services Market Size and Growth Rate (2020-2025) & (M USD)
Figure 96. Egypt Oncolytic Virus Manufacturing Services Sales and Growth Rate (2020-2025) & (K Units)
Figure 97. Egypt Oncolytic Virus Manufacturing Services Market Size and Growth Rate (2020-2025) & (M USD)
Figure 98. Nigeria Oncolytic Virus Manufacturing Services Sales and Growth Rate (2020-2025) & (K Units)
Figure 99. Nigeria Oncolytic Virus Manufacturing Services Market Size and Growth Rate (2020-2025) & (M USD)
Figure 100. South Africa Oncolytic Virus Manufacturing Services Sales and Growth Rate (2020-2025) & (K Units)
Figure 101. South Africa Oncolytic Virus Manufacturing Services Market Size and Growth Rate (2020-2025) & (M USD)
Figure 102. Global Oncolytic Virus Manufacturing Services Production Market Share by Region (2020-2025)
Figure 103. North America Oncolytic Virus Manufacturing Services Production (K Units) Growth Rate (2020-2025)
Figure 104. Europe Oncolytic Virus Manufacturing Services Production (K Units) Growth Rate (2020-2025)
Figure 105. Japan Oncolytic Virus Manufacturing Services Production (K Units) Growth Rate (2020-2025)
Figure 106. China Oncolytic Virus Manufacturing Services Production (K Units) Growth Rate (2020-2025)
Figure 107. Global Oncolytic Virus Manufacturing Services Sales Forecast by Volume (2020-2035) & (K Units)
Figure 108. Global Oncolytic Virus Manufacturing Services Market Size Forecast by Value (2020-2035) & (M USD)
Figure 109. Global Oncolytic Virus Manufacturing Services Sales Market Share Forecast by Type (2026-2035)
Figure 110. Global Oncolytic Virus Manufacturing Services Market Share Forecast by Type (2026-2035)
Figure 111. Global Oncolytic Virus Manufacturing Services Sales Forecast by Application (2026-2035)
Figure 112. Global Oncolytic Virus Manufacturing Services Market Share Forecast by Application (2026-2035)
